EUVIMEDEUVIMED entdecken
Open Access

Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression

Yiguan Chen, Xiang-Zheng Gao, Dade Rong, Liangliang Gao, Mingzhu Tang, Guang Lu, Zhi-Qiang Ling, Han-Ming Shen

International Journal of Biological Sciences · 23.04.2026 · 22 (9) · 4618-4632

DOI: 10.7150/ijbs.124757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 23.04.2026. Verfasst von Yiguan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Ministry of Education Frontier Science Centre for Precision Oncology, University of Macau, Macau SAR, China. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Quassins, Carcinoma, Non-Small-Cell Lung, Protein Serine-Threonine Kinases. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kelch-Like ECH-Associated Protein 1QuassinsCarcinoma, Non-Small-Cell LungProtein Serine-Threonine KinasesLung NeoplasmsProto-Oncogene Proteins c-aktCanagliflozinHumansAMP-Activated Protein Kinase KinasesAnimalsCell Line, TumorMiceMice, NudeApoptosisMutationSignal TransductionNF-E2-Related Factor 2

Stichwörter der Autor:innen

BrusatolCanagliflozinKEAP1LKB1NRF2NSCLC

Substanzen

Kelch-Like ECH-Associated Protein 1QuassinsSTK11 protein, humanAMP-Activated Protein Kinase KinasesbrusatolProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktCanagliflozinKEAP1 protein, humanNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Faculty of Health Sciences, Ministry of Education Frontier Science Centre for Precision Oncology, University of Macau, Macau SAR, China.
  • Department of Physiological Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

Zitieren

APA

Chen, Y., Gao, X. Z., Rong, D., Gao, L., Tang, M., Lu, G., Ling, Z. Q., & Shen, H. M. (2026). Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression. International Journal of Biological Sciences, 22(9), 4618-4632. https://doi.org/10.7150/ijbs.124757

Vancouver

Chen Y, Gao XZ, Rong D, Gao L, Tang M, Lu G, et al. Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression. International Journal of Biological Sciences. 2026;22(9):4618-4632. doi:10.7150/ijbs.124757

BibTeX
@article{Chen2026,
  author = {Chen, Yiguan and Gao, Xiang-Zheng and Rong, Dade and Gao, Liangliang and Tang, Mingzhu and Lu, Guang and Ling, Zhi-Qiang and Shen, Han-Ming},
  title = {Canagliflozin and Brusatol Synergize against LKB1-KEAP1 Co-Mutant NSCLC through AKT Suppression},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {9},
  pages = {4618--4632},
  doi = {10.7150/ijbs.124757}
}
Kostenlos starten →